XORTX Therapeutics XRTX
NASDAQ XRTX
$0.95 -0.04 (-4.30%)
As of: Oct 21, 2026 · 2:59 PM EDT

XORTX Therapeutics (XRTX) Asset Utilization Ratio (2023)

Updated

Analysis

XORTX Therapeutics (XRTX) Asset Utilization Ratio (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,136.62 Bn 1,105.21 Bn 19.71 Bn 0.62
2 Johnson & Johnson 617.59 Bn 536.12 Bn 17.26 Bn 0.49
3 AbbVie 501.69 Bn 474.80 Bn 12.70 Bn 0.47
4 Merck 368.29 Bn 322.67 Bn 12.21 Bn 0.52
5 Novartis Ag 297.79 Bn 261.78 Bn 11.24 Bn 0.46
6 Astrazeneca 260.82 Bn 234.50 Bn 12.86 Bn 0.51
7 Amgen 236.53 Bn 191.93 Bn 7.24 Bn 0.40
8 Gilead Sciences 191.14 Bn 165.33 Bn 6.22 Bn 0.58
9 Pfizer 169.69 Bn 116.33 Bn 10.94 Bn 0.31
10 XORTX Therapeutics 898,160.24 -2.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.25
API Access

XORTX Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=XRTX&period=max&api_key=YOUR_API_KEY